Verastem, Inc. VSTM

Updated: 9 Aug 2026

NASDAQ | Biotech | Biotechnology / Oncology

No signal published yet

We already track Verastem and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Verastem free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biotechnology / Oncology
We're already tracking Verastem, Inc. — here are the latest events we've registered

Recent News

  • On August 6, 2026, Verastem reported its second-quarter 2026 financial results, highlighting $25.1 million in net product revenue for AVMAPKI FAKZYNJA CO-PACK. The company also entered into a royalty financing agreement with Oberland Capital for up to $75 million and received a $15 million sales milestone payment.

What Firelda Watch includes for Verastem, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Verastem, Inc. will be delivered in the same format.

Want to follow Verastem, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Verastem free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Verastem, Inc. VSTM
Verastem — follow and we'll monitor it
Follow Verastem free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.